SCHEMBL6565522

SCHEMBL6565522

O=C(Nc1cc(-c2nc3ccccc3s2)cc(Cl)c1O)NC1CCCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.56
NPC1 O15118 4/20 0.56
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
ALDH1A1 P00352 3/20 0.56
NFKB1 P19838 1/20 0.56
NFKB2 Q00653 1/20 0.56
RELA Q04206 1/20 0.56
MAOB P27338 1/20 0.50
MGLL Q99685 1/20 0.48
MAPT P10636 6/20 0.45
TP53 P04637 6/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
KDM4E B2RXH2 3/20 0.44
HPGD P15428 2/20 0.44
HSD17B10 Q99714 1/20 0.44
HTT P42858 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4342086 0.88 ALDH1A1 (0.48) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL4342081 0.86 MAPT (0.43) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL6566878 0.83 MAPT (0.53) RAB9ANPC1MEN1KMT2ANFKB1
SCHEMBL4505884 0.82 TP53 (0.52) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL4355895 0.82 RAB9A (0.58) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL6526530 0.81 MAPT (0.51) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL4342090 0.80 MAOB (0.47) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL4347962 0.79 MAPT (0.48) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL6524162 0.79 NAMPT (0.57) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL6568636 0.78 KDM4E (0.49) RAB9ANPC1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed